Consolidated Balance Sheets - USD ($)	Apr. 30, 2019	Jul. 31, 2018
Current Assets
Cash and cash equivalents	$ 2,105	$ 53,971
Assets from discontinued operation		400,000
Total Current Assets	2,105	453,971
TOTAL ASSETS	2,105	453,971
Current Liabilities
Accounts payable and accrued liabilities	34,483	18,711
Due to a related party	235,294	235,294
Convertible notes payable	300,476	90,938
Liabilities from discontinued operations	19,500
Total Current Liabilities	589,753	344,943
TOTAL LIABILITIES	589,753	344,943
Stockholders' Equity (Deficit)
Common stock: 300,000,000 authorized; $0.001 par value; 79,792,286 and 78,542,286 shares issued and outstanding April 30, 2019 and July 31, 2018, respectively	79,792	78,542
Additional paid in capital	11,589,675	11,365,925
Accumulated deficit	(12,257,115)	(11,335,439)
Total Stockholders' Equity (Deficit)	(587,648)	109,028
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 2,105	$ 453,971

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.